Stay updated with breaking news from Ardelyx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) insider David P. Rosenbaum sold 17,872 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $7.00, for a total transaction of $125,104.00. Following the sale, the insider now directly owns 158,502 shares in the […]
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 33,040,000 shares, a drop of 6.1% from the April 30th total of 35,170,000 shares. Based on an average daily trading volume, of 5,610,000 shares, […]
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) CEO Michael Raab sold 7,500 shares of the firm’s stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $6.72, for a total transaction of $50,400.00. Following the sale, the chief executive officer now owns 1,270,273 shares in the company, valued […]
Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month […]
Piper Sandler reissued their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Friday morning, Benzinga reports. The firm currently has a $15.00 target price on the biopharmaceutical company’s stock. ARDX has been the topic of a number of other research reports. SVB Leerink began coverage on shares of […]